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ABSTRACT 
Background and Objective: Kidney stone disease goes back to thousands of years ago. 
Extracorporeal Shock Wave Lithotripsy (ESWL) is currently the first line treatment for this 
disease. Different analgesics were already used to relieve pain in the patients but they still 
complain about their pain. Therefore, the effect of two combinations of pregabalin-fentanyl 
and midazolam-fentanyl was investigated in controlling pain in the patients undergoing 
ESWL in this study. 
Materials and Methods: This was double-blind clinical trial on 141 patients visiting 
Lithotripsy Unit in Peymaniyeh Hospital in Jahrom Town.  
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The participants were selected using a simple sampling method. Inclusion criterion was 8mm 
< kidney stone < 20mm. Exclusion criteria were 20 kg/m2 < body mass index (BMI) < 30 
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kg/m2, a history of mental disorders, namely addiction to analgesics and opiates. Finally, the 
patients were randomly assigned to two groups. One microgram per kilogram fentanyl was 
administered intravenously and 300mg pregabalin was given orally to the patients ten minutes 
before surgery in the first group (pregabalin-fentanyl and n = 47). One microgram per 
kilogram fentanyl and one microgram per kilogram midazolam were injected intravenously to 
the patients ten minutes prior to operation in the second group (fentanyl-midazolam and n = 
46). Then, standard shock wave lithotripsy was carried out in both groups. The severity of 
pain was measured every 20 minutes during the operation and two hours after the operation 
using the Visual Analog Scale for Pain (VAS Pain). The collected data was analyzed using 
SPSS version 21. Descriptive statistics (mean, standard deviation and percent) and analytical 
statistical tests (Mann-Whitney and Chi-square) were used to analyze the data. 
Results: The mean age of participants was 43.80±13.71 in the first group (pregabalin + 
fentanyl) and 39.0±11.19 in the second group (midazolam + fentanyl). Chi-square test results 
were matched in both groups in terms of age, gender, number of shocks and size of the stone. 
The Mann-Whitney test results showed a significant difference between the first and second 
groups in terms of pain score from the first 20 minutes up to 2 hours after drug administration 
(p-value<0.05). The results also showed that the number of patients experiencing higher than 
average severity of pain in the second group was significantly less than the first group (p-
value<0.05). 
Conclusion: The results of this study showed that the number of patients experiencing higher 
than average severity of pain in the group receiving midazolam-fentanyl combination was less 
than the group receiving pregabalin-fentanyl combination. Therefore, it can be deduced that 
fentanyl in combination with midazolam has a greater analgesic effect on pain relief in the 
patients undergoing ESWL. 




Kidney stone disease is one of the oldest diseases. Many people are dealing with this disease 
for thousands of years (1). Some substances deposit in the supersaturated urine and form 
stones (2). The prevalence of this disease varies from 4% to 15% worldwide (3). 
Extracorporeal Shock Wave Lithotripsy (ESWL) is currently the first line treatment for the 
patients with kidney stones. The patients undergoing ESWL still complain about their pain 
despite many efforts made to control and manage postoperative pain (4). Several physical 
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variables are already identified that affect the severity of pain in the patients undergoing 
ESWL including source of shockwave, size and location of the stone and pressure threshold 
for shock wave (7-5). Several patient-related factors were also identified that are effective in 
severity of pain including age, gender and physical characteristics (8). It was also shown that 
young female, depressed, anxious and thin patients have experienced more pain during the 
operation (10, 9). Different analgesics are needed to control the pain caused by shock waves 
in addition to invention of new generations of ESWL [for complete pain relief in the patients]. 
These analgesics include opioids (e.g. morphine and fentanyl), non-steroidal anti-
inflammatory drugs (e.g. ketorolac, propofol and piroxicam) and cutaneous creams including 
eutectic mixture of local anesthetic cream (EMAA). These are either used alone or in 
combination with other drugs. Each of these has some advantages and disadvantages (11 and 
12). Fentanyl is a potent industrial narcotic with the greatest efficacy in the shortest time. This 
drug acts as a strong µ-opioid receptor agonist and moderates the severity of pain in the 
patients undergoing ESWL. For this reason, it is commonly used to relieve pain (13). Such 
opioids as fentanyl can be used alone or in combination with other analgesics (14-16). 
Midazolam is currently known as an opioid with analgesic and antianxiety effects (17). This 
drug is categorized in benzodiazepine pharmacologic class. It has the highest efficacy in the 
shortest possible time (30 to 60 seconds) (18). Pregabalin is known as a structural analogue of 
gamma-aminobutyric acid (GABA). It inhibits calcium receptors, which inhibits the release of 
neurotransmitters (e.g. glutamate and dopamine) (19). It also relieves pain and reduces 
anxiety and dependence on opioids (21 and 20). It is necessary to examine analgesic effect of 
new drugs (either alone or in combination with each other) given that a unique model and 
guideline are not given for controlling the pain of patients undergoing ESWL. Therefore, the 
present study aimed to compare the analgesic effect of two combinations of pregabalin-
fentanyl and midazolam-fentanyl. 
 
METHOD  
This was a double-blind clinical trial. The license for scientific procedure was obtained from 
the ethics committee of Jahrom University of Medical Sciences. The participants consisted of 
141 patients visiting the lithotripsy unit in Peymani Hospital in Jahrom Town. The simple 
sampling method was used to select the participants. Inclusion criteria were 20<age<50, ASA 
I and ASA II, consent of the patients to participate in the project, 8mm<stone size<20mm. 
Exclusion criteria were 20kg/m2<BMI<30kg/m2, history of mental disorders, history of 
cardiovascular diseases, history of respiratory diseases, bleeding disorders, peptic ulcer, active 
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urinary tract infection, addition to analgesics and opioids and uncooperative patients. Past 
medical history of the patients was collected and a complete physical examination was 
performed. The baseline serum tests were taken, namely sodium, potassium, total blood 
count, coagulation, renal function tests (blood urea nitrogen and creatinine), full urine test and 
urine culture. Those who were not eligible for the study were excluded from the project. One 
microgram per kilogram fentanyl was administered intravenously and 300mg pregabalin was 
given orally to the patients ten minutes before the surgery in the first group (pregabalin-
fentanyl and n = 47). One microgram per kilogram fentanyl and one microgram per kilogram 
midazolam were injected intravenously to the patients ten minutes prior to operation in the 
second group (fentanyl-midazolam and n = 46). Then, lithotripsy was performed with 
fluoroscopic projections in a standard manner in a supine position using Arian device in both 
groups. The severity of pain was measured every 20 minutes during the operation and two 
hours after the operation with the Visual Analog Scale for Pain (VAS Pain). The severity of 
pain was categorized into three classes, namely mild, moderate and severe. The severity of 
pain was scored as painless=0, 1< mild pain< 30, 30<moderate pain<70 and severe pain>70. 
Then, the patients were followed-up within two hours after the operation. The collected data 
was analyzed using SPSS version 21. Descriptive statistics (mean, standard deviation and 
percentages) and analytical statistical tests (Mann-Whitney and Chi-square) were used to 
analyze the data 
 
FINDINGS  
The mean age of the patients was 43.80 ± 13.71 in the first group (pregabalin + fentanyl)and 
39.0 ± 11.19 in the second group (midazolam + fentanyl). Chi-square test results were 
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Table 1. Comparison of the two groups in terms of demographic factors 
Group 






Gender1 Male 33 (71.7) 28 (59.6) 0.217 
Female 13 (28.3) 19 (40.4)  
Age2  39.0±11.19 43.80±13.71 0.140 
The number of shockwaves2 2741±289.5 2721±320.96 0.411 
The stone size2 12.36±4.24 12.35±3.81 0.923 
1 Frequency (percent)  
2 Mean ± standard deviation  
 
The Mann-Whitney test results showed a significant difference between pregabalin-fentanyl 
and midazolam-fentanyl groups in terms of pain score in 20 minutes and 2 hours after drug 
administration (p-value <0.05) (Table 2). 
 
Table 2. Comparison of pain score in ESWL in pregabalin + fentanyl and midazolam + 
fentanyl groups 
Group 
Factor  Midazolam + 
fentanyl (n=46) 





0(1-0) 0(1-0) 0.084 
After 20min 0(0-0) 3(3-3) 0.00 
After 40min 0(1-0) 3(3-3) 0.00 
After 1h 0(0-0) 3(3-3) 0.00 
After 2h 0(1-0) 3(3-3) 0.00 
p-value 0.00 0.00  
Median (Q3-Q1) 
 
Twenty minutes after taking the drug, 43 patients (91.5%) experienced severe pain, 2 patients 
(4.3%) experienced mild pain in the first group (pregabalin + fentanyl). However, 38 patients 
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(82.6%) were painless and 5 patients (10.9%) experienced mild pain in the second group 
(midazolam + fentanyl). Forty minutes after taking the drug, 43 patients (91.5%) experienced 
severe pain and 2 patients (4.3%) were painless in the first group. However, 30 patients 
(65.2%) patients were painless and 10 patients (21.7%) experienced mild pain in the second 
group. One hour after taking the drug, 44 patients (93.6%) experienced severe pain and 2 
patients (4.3%) were painless in the first group. However, 39 patients (84.8%) were painless 
and 4 patients (8.7%) experienced mild pain in the second group. Two hours after taking the 
drug, 37 patients (78.7%) experienced severe pain and 6 patients (12.8%) experienced 
moderate pain in the first group. However, 25 patients (54.3%) were painless and 12 patients 
(26.1%) experienced mild pain in the second group (Table 3). 
 
Table 3. Frequency of severity of pain in ESWL in pergabalin + fentanyl and midazolam + 
fentanyl groups 
 Fentanyl + midazolam 
(n=46) 
pregabalin + fentanyl (n=47) 
Number Percent Number Percent 
Before drug 
administration 
Painless 27 58.7% 35 74.5% 
Mild pain 15 32.6% 11 23.4% 
Moderate 
pain 
3 6.5% 1 2.1% 
Severe pain 1 2.2% 0 0.0% 
After 20min Painless 38 82.6% 2 4.3% 
Mild pain 5 10.9% 2 4.3% 
Moderate 
pain 
3 6.5% 0 0.0% 
Severe pain 0 0.0% 43 91.5% 
After forty 
minutes 
Painless 30 65.2% 2 4.3% 
Mild pain 10 21.7% 1 2.1% 
Moderate 
pain 
4 8.7% 1 2.1% 
Severe pain 2 4.3% 43 91.5% 
After one hour Painless 39 84.8% 2 4.3% 
Mild pain 4 8.7% 1 2.1% 
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Moderate 
pain 
2 4.3% 0 0.0% 
Severe pain 1 2.2% 44 93.6% 
After two 
hours 
Painless 25 54.3% 4 8.5% 
Mild pain 12 26.1% 0 0.0% 
Moderate 
pain 
5 10.9% 6 12.8% 
Severe pain 4 8.7% 37 78.7% 
 
DISCUSSION 
ESWL is the first line treatment for the patients with upper urinary tract stones. The patients 
treated with ESWL still complain about their pain despite invention of new generation of 
ESWL. Therefore, is necessary to use analgesics to relieve pain in the patients more easily. 
Simple painkillers, opioids and non-steroidal anti-inflammatory drugs are the most important 
drugs used so far. However, the effectiveness of these drugs is relative. No certain guideline is 
also given for prescription of these drugs (22). The results of this study showed that 
combination of midazolam and fentanyl is more effective in reducing the severity of pain in 
the patients undergoing ESWL than pregabalin-fentanyl combination. The results of this study 
are consistent with the results of other studies. Some of these studies are mentioned here. For 
example, Zeyneloglu et al. (2008) also aimed to compare analgesic and soothing effect of 
midazolam-fentanyl combination and dexmedetomidine in the patients undergoing ESWL. 
Most of the patients in the control (midazolam-fentanyl) were more satisfied with their 
medication, more relieved and painless than the intervention group (dexmedetomidine) during 
the surgery (23). Yang et al. (2002) compared the effect of midazolam-fentanyl and 
midazolam-ketorolac combinations for controlling pain in the patients undergoing ESWL. 
They showed that both combinations are effective in pain relief but the combination of 
midazolam- ketorolac has less side effects (24). Action mode of midazolam-fentanyl 
combination is interpreted in the below. Fentanyl and midazolam are opiate and sedative 
drugs. These drugs act on the central nervous system, increase the levels of endorphins and 
eliminate pain1 in the patients undergoing ESWL (25). Kalni et al. (2016) also compared the 
effect of midazolam and melatonin in controlling pain in the patients undergoing ESWL. The 
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severity of pain in the patients receiving midazolam is significantly less than those receiving 
melatonin (26). According to the results of the above-mentioned studies, the combination of 
midazolam and fentanyl has less side effects and is highly efficient in controlling pain in the 
patients undergoing ESWL. It can also be used for pain relief in outpatient ESWL. Some 
evidence suggests that the patients receiving GABA analogs (e.g. pregabalin and gabapentin) 
require less painkillers during the operation and these analogs relieve pain for a longer time. 
However, the results of the present study showed that pregabalin in combination with fentanyl 
does not reduce the severity of pain in the patients undergoing ESWL. Radmehr et al. (2017) 
also compare the analgesic effect of pregabalin and melatonin in the patients undergoing 
ESWL. The severity of pain increased during and after the operation in the patients given 
placebo, melatonin, and pregabalin. No significant difference was found between the three 
groups (27). Therefore, GABA analogs alone are not enough to relieve pain in patients. It is 
recommended to use different doses of this combination to achieve different results. On the 
other hand, the number of patients with higher than average pain in the midazolam-fentanyl 
group was less than the pregabalin-fentanyl group. In other words, the patients receiving 
midazolam-fentanyl experienced less pain than the group receiving the combination of 
pregabalin and fentanyl. Mehrabi et al. (2011) also aimed to compare the efficacy and side 
effects of fentanyl opiate drug and pethidine and midazolam combination for controlling pain 
during ESWL. They showed that more people experienced higher than average severity of 
pain in the pethidine-midazolam group compared to the fentanyl group (25). 
 
CONCLUSION 
The results of this study showed that less people experienced higher than average severity of 
pain in the group receiving midazolam-fentanyl compared to the group receiving pregabalin-
fentanyl. It can be deduced that fentanyl in combination with midazolam has a greater 
efficacy in controlling pain in the patients undergoing ESWL. Therefore, it is recommended 
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